Investigating the effect of sotalol on the repolarization intervals in healthy young individuals

Journal of Electrocardiology

Volumn 41, Issue 6, 2008, Pages 595-602

  Couderc, Jean Philippe ^a   Zhou, Meijian ^b   Sarapa, Nenad ^c   Zareba, Wojciech ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

^b ICARDIAC TECHNOLOGIES INC   (United States)

^c JOHNSON AND JOHNSON   (United States)

Author keywords

ECG; Long QT syndrome; QT interval; Sotalol; Torsades de pointes; Vectocardiography

Indexed keywords

SOTALOL;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; HEART REPOLARIZATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QT PROLONGATION; REPOLARIZATION; T WAVE;

ADULT; ALGORITHMS; ANTI-ARRHYTHMIA AGENTS; DIAGNOSIS, COMPUTER-ASSISTED; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOTALOL;

EID: 55649110026     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2008.06.013     Document Type: Article

References (39)

1. Zareba W., Moss A.J., le Cessie S., et al. Risk of cardiac events in family members of patients with long QT syndrome. J Am Coll Cardiol 26 (1995) 1685
2. Wysowski D.K., Corken A., Gallo-Torres H., Talarico L., and Rodriguez E.M. Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions. Am J Gastroenterol 96 (2001) 1698
3. Woosley R.L., Chen Y., Freiman J.P., and Gillis R.A. Mechanism of the cardiotoxic actions of terfenadine. JAMA 269 (1993) 1532
4. Akdeniz B., Guneri S., Savas I.Z., et al. Effects of carvedilol therapy on arrhythmia markers in patients with congestive heart failure. Int Heart J 47 (2006) 565
5. Liu X.K., Katchman A., Ebert S.N., and Woosley R.L. The antiestrogen tamoxifen blocks the delayed rectifier potassium current, IKr, in rabbit ventricular myocytes. J Pharmacol Exp Ther 287 (1998) 877
6. Antzelevitch C. Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes. Am J Physiol Heart Circ Physiol 293 (2007) H2024
7. Hondeghem L.M. TRIad: foundation for proarrhythmia (triangulation, reverse use dependence and instability). Novartis Found Symp 266 (2005) 235
8. Belardinelli L., Antzelevitch C., and Vos M.A. Assessing predictors of drug-induced torsade de pointes. Trends Pharmacol Sci 24 (2003) 619
9. Yan G.X., Wu Y., Liu T., Wang J., Marinchak R.A., and Kowey P.R. Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome: direct evidence from intracellular recordings in the intact left ventricular wall. Circulation 103 (2001) 2851
10. Okin P.M., Devereux R.B., Fabsitz R.R., Lee E.T., Galloway J.M., and Howard B.V. Principal component analysis of the T wave and prediction of cardiovascular mortality in American Indians: the Strong Heart Study. Circulation 105 (2002) 714
11. Couderc JP. Interest of Ikr-related abnormalities of ECGs to improve drug-safety evaluation: preliminary results from the FDA ECG Warehouse and the International Registry for the Congenital LQTS. 5-8-2006. Drug Information Association: challenges and practical aspects of assessing clinical QT prolongation/proarrhythmia risk and implications for the critical pathway. Fairmont Hotel, 8 May 2006, Washington, DC. 5-8-2006. Ref Type: Personal Communication
12. Opthof T., Coronel R., Wilms-Schopman F.J., et al. Dispersion of repolarization in canine ventricle and the electrocardiographic T wave: Tp-e interval does not reflect transmural dispersion. Heart Rhythm 4 (2007) 341
13. Takenaka K., Ai T., Shimizu W., et al. Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome. Circulation 107 (2003) 838
14. Watanabe N., Kobayashi Y., Tanno K., et al. Transmural dispersion of repolarization and ventricular tachyarrhythmias. J Electrocardiol 37 (2004) 191
15. Xia Y., and Yuan S. In vivo validation of the T-peak to T-end interval: implications for genesis of the T wave. Heart Rhythm 4 (2007) 349
16. Hinterseer M., Thomsen M.B., Beckmann B.M., et al. Beat-to-beat variability of QT intervals is increased in patients with drug-induced long-QT syndrome: a case control pilot study. Eur Heart J 29 (2008) 185
17. Yalta K., Turgut O., Yilmaz A., Yilmaz M.B., Kendirlioglu O., and Karadas F. Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake. Int J Cardiol 116 (2007) e95
18. Sarapa N., Morganroth J., Couderc J.P., et al. Electrocardiographic identification of drug-induced QT prolongation assessment by different recording and measurement methods. Ann Noninvasive Electrocardiol 9 (2004 January) 48
19. Couderc JP, Vaglio M, Xia X, McNitt S, Hyrien O. Electrocardiographic method for identifying drug-induced repolarization abnormalities associated with a reduction of the rapidly activating delayed rectifier potassium current. Engineering in Medicine and Biology Society; 2006, EMBS '06, 28th Annual International Conference of the IEEE. p. 4010.
20. Couderc J.P., Vaglio M., Xia X., et al. Impaired T-amplitude adaptation to heart rate characterizes I(Kr) inhibition in the congenital and acquired forms of the long QT syndrome. J Cardiovasc Electrophysiol 18 (2007) 1299
21. Couderc J.P., McNitt S., Hyrien O., et al. Improving the detection of subtle i(kr)-inhibition: assessing electrocardiographic abnormalities of repolarization induced by moxifloxacin. Drug Saf 31 (2008) 249
22. Sarapa N., Morganroth J., Couderc J.P., et al. Electrocardiographic identification of drug-induced QT prolongation: assessment by different recording and measurement methods. Ann Noninvasive Electrocardiol 9 (2004) 48
23. Kanters J.K., Fanoe S., Larsen L.A., Bloch Thomsen P.E., Toft E., and Christiansen M. T wave morphology analysis distinguishes between KvLQT1 and HERG mutations in long QT syndrome. Heart Rhythm 1 (2004) 285
24. Lehmann M.H., Suzuki F., Fromm B.S., et al. T wave "humps" as a potential electrocardiographic marker of the long QT syndrome. J Am Coll Cardiol 24 (1994) 746
25. Malfatto G., Beria G., Sala S., Bonazzi O., and Schwartz P.J. Quantitative analysis of T wave abnormalities and their prognostic implications in the idiopathic long QT syndrome. J Am Coll Cardiol 23 (1994) 296
26. Moss A.J., Zareba W., Benhorin J., et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 92 (1995) 2929
27. Schwartz P.J., Moss A.J., Vincent G.M., and Crampton R.S. Diagnostic criteria for the long QT syndrome. An update. Circulation 88 (1993) 782
28. Struijk J.J., Kanters J.K., Andersen M.P., et al. Classification of the long QT syndrome based on discriminant analysis of T-wave morphology. Med Biol Eng Comput 44 (2006 July) 543
29. Zhang L., Timothy K.W., Vincent G.M., et al. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation 102 (2000) 2849
30. Padrini R., Butrous G., Statters D., Camm A.J., and Malik M. Morphological algebraic models of the TU-wave patterns/in idiopathic long QT syndrome. Int J Cardiol 77 (2001) 151
31. Vaglio M., Couderc J.P., McNitt S., Xia X., Moss A.J., and Zareba W. A quantitative assessment of T-wave morphology in LQT1, LQT2, and healthy individuals based on Holter recording technology. Heart Rhythm 5 (2008) 11
32. Vaglio M., Couderc J.P., Xia X., and Zareba W. Fractionated repolarization velocity induced by sotalol in healthy subjects. Comput Cardiol 2005 (2005) 523
33. Couderc J.P., Kaab S., Hinterseer M., et al. Baseline values and drug-induced changes of the ventricular repolarization morphology in the electrocardiograms of patients with a history of drug-induced torsades de pointes. J Clin Pharmacol (2006) [in press]
34. Han J., and Moe G.K. Nonuniform recovery of excitability in ventricular muscle. Circ Res 14 (1964) 44
35. Shimizu M., Ino H., Okeie K., et al. T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion. Clin Cardiol 25 (2002) 335
36. Sicouri S., Moro S., Litovsky S., Elizari M.V., and Antzelevitch C. Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart. J Cardiovasc Electrophysiol 8 (1997) 1269
37. van Opstal J.M., Schoenmakers M., Verduyn S.C., et al. Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome. Circulation 104 (2001) 2722
38. Benhorin J., Merri M., Alberti M., et al. Long QT syndrome. New electrocardiographic characteristics. Circulation 82 (1990) 521
39. Extramiana F., Haggui A., Maison-Blanche P., et al. T-wave morphology parameters based on principal component analysis reproducibility and dependence on T-offset position. Ann Noninvasive Electrocardiol 12 (2007) 354